DLA Piper partner John J. Clarke Jr. has entered an appearance for Bristol-Myers Squibb in a securities class action over the company's 2019 acquisition of Celgene Corp. The action was filed Oct. 6 in New York Southern District Court by Labaton Sucharow and Entwistle & Cappucci on behalf of former Celgene shareholders. The case, assigned to U.S. District Judge Jesse M. Furman, is 1:21-cv-08255, Sm Merger/Arbitrage, L.P. et al v. Bristol-Myers Squibb Company et al.
Biotech & Pharmaceuticals
October 28, 2021, 7:42 AM